NEW YORK — Kantaro Biosciences said on Wednesday that its COVID-SeroKlir SARS-CoV-2 antibody test has received Emergency Use Authorization from the US Food and Drug Administration.
NEW YORK — Kantaro Biosciences said on Wednesday that its COVID-SeroKlir SARS-CoV-2 antibody test has received Emergency Use Authorization from the US Food and Drug Administration.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.